Title:
NOVEL IMIDAZOLE DERIVATIVE EXPRESSING FLT3 INHIBITORY ACTIVITY, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/029665
Kind Code:
A1
Abstract:
The present invention relates to a novel benzoimidazole derivative expressing fms-like tyrosine kinase 3 (FLT3) inhibitory activity, and a use thereof. A novel benzoimidazole derivative or a pharmaceutically acceptable salt thereof, according to the present invention, exhibits excellent inhibitory activity on FLT3, and thus targeted treatment through more fundamental approaches is expected in the prevention or treatment of acute myeloid leukemia (AML).
Inventors:
HAH JUNG MI (KR)
IM DA SEUL (KR)
IM DA SEUL (KR)
Application Number:
PCT/KR2020/010667
Publication Date:
February 18, 2021
Filing Date:
August 12, 2020
Export Citation:
Assignee:
IUCF HYU ERICA CAMPUS (KR)
International Classes:
C07D413/12; A61K31/422; A61K31/454; A61K31/496; A61K31/5377; A61P35/02; C07D413/14
Foreign References:
| KR20110040384A | 2011-04-20 | |||
| KR20160125527A | 2016-10-31 | |||
| CN109970717A | 2019-07-05 | |||
| US20110281917A1 | 2011-11-17 | |||
| KR20100137742A | 2010-12-31 |
Attorney, Agent or Firm:
DANA PATENT LAW FIRM (KR)
Download PDF:
Previous Patent: WAKE UP SIGNAL CONFIGURATION
Next Patent: TECHNIQUE FOR IDENTIFYING TRANSMISSION MODE OF NGV PPDU IN WIRELESS COMMUNICATION SYSTEM
Next Patent: TECHNIQUE FOR IDENTIFYING TRANSMISSION MODE OF NGV PPDU IN WIRELESS COMMUNICATION SYSTEM